Immunomodulatory effects of a probiotic drink containing Lactobacillus casei Shirota in healthy older volunteers
- 1.2k Downloads
There is growing evidence that probiotics confer health benefits to the host by modulating immune function, especially in older people, where immunosenescence is a feature even of healthy ageing. The aim of this study was to investigate the effect of a probiotic drink containing Lactobacillus casei Shirota (LcS) on immune function in a healthy non-immunocompromised older population.
Thirty healthy old volunteers were recruited into a randomized placebo-controlled, single-blind crossover study. The volunteers were supplemented with the probiotic drink containing 1.3 × 1010 CFU LcS or skimmed milk per day for 4 weeks, followed by 4 weeks of washout and were crossed over to the other treatment. Peripheral blood and saliva samples were collected at baseline and end of each treatment.
Probiotic consumption was associated with a significant increase in natural killer (NK) cell activity relative to baseline and a significant decrease in the mean fluorescence intensity of CD25 expression in the resting T cells compared with placebo. Additionally, there was a trend towards an increased ratio of IL-10 to IL-12 relative to baseline after LcS intake.
Consumption of a probiotic drink containing LcS improved NK cell activity and tended to produce a more anti-inflammatory cytokine profile in an older population.
KeywordsCytokine Immune function Lactobacillus casei Shirota Lymphocyte Probiotic
All authors contributed to the study design, analysis of the data and preparation of the manuscript. All authors read and approved the final manuscript.
Conflict of interest
This research was sponsored by a Dorothy Hodgkin Postgraduate Award and Yakult UK Limited. Dr. Thomas is an employee of Yakult UK Limited.
- 2.Bunout D, Barrera G, Hirsch S, Gattas V, de la Maza MP, Haschke F, Steenhout P, Klassen P, Hager C, Avendano M, Petermann M, Munoz C (2004) Effects of a nutritional supplement on the immune response and cytokine production in free-living Chilean elderly. J Parenter Enter Nutr 28(5):348–354CrossRefGoogle Scholar
- 3.Gill HS, Rutherfurd KJ, Cross ML, Gopal PK (2001) Enhancement of immunity in the elderly by dietary supplementation with the probiotic Bifidobacterium lactis HN019. Am J Clin Nutr 74(6):833–839Google Scholar
- 6.Zanini K, Marzotto M, Castellazzi A, Borsari A, Dellaglio F, Torriani S (2007) The effects of fermented milks with simple and complex probiotic mixtures on the intestinal microbiota and immune response of healthy adults and children. Int Dairy J 17(11):1332–1343. doi: 10.1016/j.idairyj.2007.01.017 CrossRefGoogle Scholar
- 9.Tuohy KM, Pinart-Gilberga M, Jones M, Hoyles L, McCartney AL, Gibson GR (2007) Survivability of a probiotic Lactobacillus casei in the gastrointestinal tract of healthy human volunteers and its impact on the faecal microflora. J Appl Microbiol 102(4):1026–1032. doi: 10.1111/j.1365-2672.2006.03154.x Google Scholar
- 11.Sakai T, Makino H, Ishikawa E, Oishi K, Kushiro A (2011) Fermented milk containing Lactobacillus casei strain Shirota reduces incidence of hard or lumpy stools in healthy population. Int J Food Sci Nutr Epub ahead of printGoogle Scholar
- 14.Gleeson M, Bishop NC, Oliveira M, Tauler P (2011) Daily probiotic’s (Lactobacillus casei Shirota) reduction of infection incidence in athletes. Int J Sport Nutr Exerc Metab 21(1):55–64Google Scholar
- 17.Kotani Y, Shinkai S, Okamatsu H, Toba M, Ogawa K, Yoshida H, Fukaya T, Fujiwara Y, Chaves PH, Kakumoto K, Kohda N (2010) Oral intake of Lactobacillus pentosus strain b240 accelerates salivary immunoglobulin A secretion in the elderly: a randomized, placebo-controlled, double-blind trial. Immun Ageing 7:11CrossRefGoogle Scholar
- 19.Olivares M, Diaz-Ropero MP, Gomez N, Lara-Villoslada F, Sierra S, Maldonado JA, Martin R, Rodriguez JM, Xaus J (2006) The consumption of two new probiotic strains, Lactobacillus gasseri CECT 5714 and Lactobacillus coryniformis CECT 5711, boosts the immune system of healthy humans. Int Microbiol 9(1):47–52Google Scholar
- 20.Christensen HR, Larsen CN, Kaestel P, Rosholm LB, Sternberg C, Michaelsen KF, Frokiaer H (2006) Immunomodulating potential of supplementation with probiotics: a dose-response study in healthy young adults. FEMS Immunol Med Microbiol 47(3):380–390. doi: 10.1111/j.1574-695X.2006.00109.x CrossRefGoogle Scholar
- 25.de Vrese M, Winkler P, Rautenberg P, Harder T, Noah C, Laue C, Ott S, Hampe J, Schreiber S, Heller K, Schrezenmeir J (2005) Effect of Lactobacillus gasseri PA 16/8, Bifidobacterium longum SP 07/3, B-bifidum MF 20/5 on common cold episodes: a double blind, randomized, controlled trial. Clin Nutr 24(4):481–491. doi: 10.1016/j.clnu.2005.02.006 CrossRefGoogle Scholar
- 27.Takeda K, Okumura K (2007) Effects of a fermented milk drink containing Lactobacillus casei strain shirota on the human NK-cell activity. J Nutr 137(3):791S–793SGoogle Scholar
- 28.Matsuzaki T, Saito M, Usuku K, Nose H, Izumo S, Arimura K, Osame M (2005) A prospective uncontrolled trial of fermented milk drink containing viable Lactobacillus casei strain Shirota in the treatment of HTLV-1 associated myelopathy/tropical spastic paraparesis. J Neurol Sci 237(1–2):75–81. doi: 10.1016/j.jns.2005.05.011 CrossRefGoogle Scholar
- 29.Aso Y, Akaza H, Kotake T, Tsukamoto T, Imai K, Naito S (1995) Preventive effect of a Lactobacillus casei preparation on the recurrence of superficial bladder-cancer in a double-blind trial. Eur Urol 27(2):104–109Google Scholar
- 32.Oshimi K, Gonda N, Sumiya M, Kano S (1980) Effects of corticosteroids on natural-killer cell activity in systemic lupus-erythematosus. Clin Exp Immunol 40(1):83–88Google Scholar
- 37.Stadlbauer V, Mookerjee R, Wright G, Hodges S, Jalan R (2008) Restoration of the defective innate immune system following treatment with the probiotic Lactobacillus casei Shirota in patients with alcoholic cirrhosis: a proof of concept study. Wien Klin Wochenschr 120(15–16):A44–A44Google Scholar
- 38.Roller M, Clune Y, Collins K, Rechkemmer G, Watzl B (2007) Consumption of prebiotic inulin enriched with oligofructose in combination with the probiotics Lactobacillus rhamnosus and Bifidobacterium lactis has minor effects on selected immune parameters in polypectomised and colon cancer patients. Br J Nutr 97(4):676–684. doi: 10.1017/s0007114507450292 CrossRefGoogle Scholar
- 40.Fukushima Y, Miyaguchi S, Yamano T, Kaburagi T, Iino H, Ushida K, Sato K (2007) Improvement of nutritional status and incidence of infection in hospitalised, enterally fed elderly by feeding of fermented milk containing probiotic Lactobacillus johnsonii La1 (NCC533). Br J Nutr 98(5):969–977. doi: 10.1017/s0007114507764723 CrossRefGoogle Scholar
- 43.Heaton PR, Blount DG, Devlin P, Koelsch S, Mann SJ, Smith BHE, Stevenson J, Harper EJ (2002) Assessing age-related changes in peripheral blood leukocyte phenotypes in labrador retriever dogs using flow cytometry. J Nutr 132(6):1655S–1657SGoogle Scholar
- 45.Olsson J, Wikby A, Johansson B, Lofgren S, Nilsson BO, Ferguson FG (2000) Age-related change in peripheral blood T-lymphocyte subpopulations and cytomegalovirus infection in the very old: the Swedish longitudinal OCTO immune study. Mech Ageing Dev 121(1–3):187–201Google Scholar
- 47.Park JH, Lee YH, Moon E, Seok SH, Cho SA, Baek MW, Lee HY, Kim DJ (2005) Immunoenhancing effects of a new probiotic strain, Lactobacillus fermentum PL9005. J Food Prot 68(3):571–576Google Scholar
- 48.Braat H, van den Brande J, van Tol E, Hommes D, Peppelenbosch M, van Deventer S (2004) Lactobacillus rhamnosus induces peripheral hyporesponsiveness in stimulated CD4(+) T cells via modulation of dendritic cell function. Am J Clin Nutr 80(6):1618–1625Google Scholar
- 49.Koebnick C, Wagner I, Leitzmann P, Stern U, Zunft HJF (2003) Probiotic beverage containing Lactobacillus casei Shirota improves gastrointestinal symptoms in patients with chronic constipation. Can J Gastroenterol 17(11):655–659Google Scholar
- 50.De Preter V, Vanhoutte T, Huys G, Swings J, De Vuyst L, Rutgeerts P, Verbeke K (2007) Effects of Lactobacillus casei Shirota, Bifidobacterium breve, and oligofructose-enriched inulin on colonic nitrogen-protein metabolism in healthy humans. Am J Physiol Gastrointest Liver Physiol 292: G358–G368CrossRefGoogle Scholar